المؤلفون: Shota Omori, Koji Muramatsu, Takuya Kawata, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Takashi Sugino, Toshiaki Takahashi

المصدر: Investigational New Drugs. 41:356-364

مصطلحات موضوعية: Pharmacology, Oncology, Pharmacology (medical)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9d7df0283c380206d7a767845fff4569Test
https://doi.org/10.1007/s10637-023-01353-8Test

المؤلفون: Hiroaki Kodama, Taichi Miyawaki, Yuko Iida, Shota Omori, Ryo Ko, Hirotsugu Kenmotsu, Haruki Kobayashi, Nobuaki Mamesaya, Takeshi Kaneko, Yuya Tabuchi, Takanori Kawabata, Hideyuki Harada, Kosei Doshita, Keita Mori, Haruyasu Murakami, Kazushige Wakuda, Toshiaki Takahashi, Tateaki Naito, Akira Ono, Eriko Miyawaki, Naoya Nishioka

المصدر: Investigational New Drugs. 40:411-419

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Lung Neoplasms, Multivariate analysis, Internal medicine, Humans, Medicine, Pharmacology (medical), Progression-free survival, Stage (cooking), Survival rate, Depression (differential diagnoses), Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, business.industry, Proportional hazards model, Retrospective cohort study, Chemoradiotherapy, Prognosis, Small Cell Lung Carcinoma, Survival Rate, Treatment Outcome, Disease Progression, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d121ca8942da6466a84ed020ac39eb02Test
https://doi.org/10.1007/s10637-021-01183-6Test

المؤلفون: Taichi Miyawaki, Hideyuki Harada, Naoya Nishioka, Michitoshi Yabe, Nakamasa Hayashi, Keita Mori, Haruyasu Murakami, Tateaki Naito, Shoichi Deguchi, Nobuaki Mamesaya, Koichi Mitsuya, Akira Ono, Toshiaki Takahashi, Kazuhisa Takahashi, Eriko Miyawaki, Hiroaki Kodama, Kazushige Wakuda, Hirotsugu Kenmotsu, Shota Omori, Haruki Kobayashi

المصدر: Investigational new drugs. 39(6)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, Sex Factors, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Pharmacology (medical), Osimertinib, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, biology, business.industry, Age Factors, Middle Aged, medicine.disease, respiratory tract diseases, ErbB Receptors, biology.protein, Female, Erlotinib, Non small cell, business, Meningeal Carcinomatosis, Leptomeningeal metastasis, medicine.drug, Epidermal growth factor receptor tyrosine kinase

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b234eceaed54f034e73b11c7b39f0ea5Test
https://pubmed.ncbi.nlm.nih.gov/34259953Test

المؤلفون: Hirotsugu Kenmotsu, Haruyasu Murakami, Tateaki Naito, Takahisa Kawamura, Shota Omori, Keita Mori, Kazushige Wakuda, Haruki Kobayashi, Kazuhisa Nakashima, Akira Ono, Toshiaki Takahashi, Masahiro Endo

المصدر: Investigational New Drugs

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, 0302 clinical medicine, Non-small cell lung cancer, Malignant effusion, Epidermal growth factor, Carcinoma, Non-Small-Cell Lung, Pharmacology (medical), Osimertinib, Aged, 80 and over, Aniline Compounds, Middle Aged, Prognosis, ErbB Receptors, Survival Rate, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Short Report, Antineoplastic Agents, 03 medical and health sciences, EGFR-TKI, Internal medicine, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Pharmacology, Acrylamides, Lung, business.industry, medicine.disease, Confidence interval, Pleural Effusion, Malignant, respiratory tract diseases, 030104 developmental biology, Drug Resistance, Neoplasm, Egfr mutation, Mutation, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bc8bb2c0ffe3932f6105917cbca7c8Test
https://doi.org/10.1007/s10637-019-00808-1Test

المؤلفون: Naoya Nishioka, Kazushige Wakuda, Taichi Miyawaki, Tateaki Naito, Eriko Miyawaki, Michitoshi Yabe, Akira Ono, Masahiro Endo, Toshiaki Takahashi, Shota Omori, Haruyasu Murakami, Haruki Kobayashi, Takahisa Kawamura, Hirotsugu Kenmotsu, Hiroaki Kodama, Nobuaki Mamesaya

المصدر: Investigational new drugs. 39(2)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Antineoplastic Agents, behavioral disciplines and activities, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Carcinoma, Humans, Pharmacology (medical), Osimertinib, Adverse effect, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, Acrylamides, Aniline Compounds, business.industry, Interstitial lung disease, Cancer, Retrospective cohort study, respiratory system, Middle Aged, medicine.disease, respiratory tract diseases, Discontinuation, body regions, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Lung Diseases, Interstitial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ad6be975b9d74603b9a46914901ce1Test
https://pubmed.ncbi.nlm.nih.gov/32955628Test

المؤلفون: Kazushige Wakuda, Kazuaki Yasui, Hideyuki Harada, Takahisa Kawamura, Masahiro Endo, Takanori Kawabata, Hiroto Inoue, Tsuyoshi Onoe, Akira Ono, Nobuaki Mamesaya, Tateaki Naito, Toshiaki Takahashi, Hirofumi Ogawa, Shota Omori, Hirotsugu Kenmotsu, Haruki Kobayashi, Haruyasu Murakami

المصدر: Investigational New Drugs. 39:899-899

مصطلحات موضوعية: 0301 basic medicine, Pharmacology, medicine.medical_specialty, Durvalumab, business.industry, medicine.medical_treatment, Odds ratio, medicine.disease, Gastroenterology, Radiation therapy, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Internal medicine, medicine, Pharmacology (medical), Lung volumes, Risk factor, business, Lung cancer, Chemoradiotherapy, Pneumonitis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1aee1d2574c149a1d45fbd48c743da94Test
https://doi.org/10.1007/s10637-020-00969-4Test

المؤلفون: Hirotsugu Kenmotsu, Tateaki Naito, Takahisa Kawamura, Kazushige Wakuda, Kazuhisa Nakashima, Shota Omori, Haruyasu Murakami, Toshiaki Takahashi, Haruki Kobayashi, Masahiro Endo, Akira Ono

المصدر: Investigational new drugs. 37(1)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Alectinib, Adult, Male, medicine.medical_specialty, Lung Neoplasms, Oncogene Proteins, Fusion, Carbazoles, Metastasis, Lesion, 03 medical and health sciences, 0302 clinical medicine, Piperidines, hemic and lymphatic diseases, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Anaplastic lymphoma kinase, Humans, Pharmacology (medical), Lung cancer, Pharmacology, business.industry, medicine.disease, Prognosis, Discontinuation, 030104 developmental biology, 030220 oncology & carcinogenesis, Non small cell, medicine.symptom, Neoplasm Recurrence, Local, business, EML4/ALK Fusion Protein, Meningeal Carcinomatosis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de6f0cde35451b2d906cb8dd462b755Test
https://pubmed.ncbi.nlm.nih.gov/29971546Test